Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon

Digestive and Liver Disease

Volumn 34, Issue 7, 2002, Pages 510-515

  Tursi, A ^c,d   Brandimarte, G ^b,c   Daffina R ^a,c  

^a Emergency Division l Bonomo Hospital   (Italy)

^b Cristo Re Hospital   (Italy)

^c ENEA   (Italy)

^d NONE   (Italy)

Author keywords

Diverticulitis; Mesalazine; Rifaximin

Indexed keywords

MESALAZINE; RIFAXIMIN; GASTROINTESTINAL AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RIFAMYCIN;

ADULT; AGED; ARTICLE; COLON DIVERTICULOSIS; COLONOSCOPY; CONTROLLED STUDY; DEATH; DEFECATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; EPIGASTRIC PAIN; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; RECURRENT DISEASE; SYMPTOM; TREATMENT OUTCOME; URTICARIA; ACUTE DISEASE; COMPARATIVE STUDY; DRUG COMBINATION; EVALUATION; HOSPITALIZATION; MIDDLE AGED; TIME;

ACUTE DISEASE; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIVERTICULITIS, COLONIC; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; MALE; MESALAMINE; MIDDLE AGED; RECURRENCE; RIFAMYCINS; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME;

EID: 0036020532     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(02)80110-4     Document Type: Article

References (22)

1. Diverticular disease of the colon
2. Diverticular disease of the colon: A deficiency disease of western civilization
3. Natural history of diverticular disease of the colon
4. Diverticular disease of the colon, a 20th century problem
5. A critical reappraisal of sigmoid peridiverticulitis
6. Diverticular disease of the colon
7. Acute left colonic diverticulitis: A prospective analysis of 226 consecutive cases
8. Diagnosis and management of diverticular disease of the colon
9. In vitro activity of rifaximin and rifampicin against some anaerobic bacteria
10. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial
11. Prolonged-release mesalazine: A review of its therapeutic potential in ulcerative colitis and Crohn's disease
12. Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial
13. Long-term treatment with rifaximin and lactobacilli in post-diverticulic stenoses of the colon
14. Cytokines in inflammatory bowel disease
15. Nitric oxide as a modulator of intestinal water and electrolyte transport
16. Potential mediators in inflammatory bowel disease
17. Oxidants and free radicals in inflammatory bowel disease
18. Inflammatory bowel disease
19. Antioxidant activity of 5-aminosalicylic acid against peroxidation of phosphatidylcholine liposomes in the presence of alpha-tocopherol: A synergistic interaction?
20. Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular disease of the large intestine. 4 year follow-up results
21. Hydrostatic balloon dilation of gastrointestinal stenoses. A national survey
22. Endoscopic alternatives in the management of colonic strictures